PROVEPHARM (US GENERICS PORTFOLIO)
Summary
The portfolio includes four FDA-approved and marketed sterile injectable drugs and two late-stage pipeline assets.
Deals Overview
Total Deals1
Valued Deals0
Total Value-
Avg. Deal Size-
All rights reserved. Copyright © 2026 Datasite